However, we found a significant difference in expression levels of lncRNA HIT in HER-2-positive breast cancer patients compared to HER-2-negative breast cancer patients (4.23 ± 4.02 vs. 2.92 ± 2.70; p = 0.005) (Table 5). The gene discussed is ERBB2; the disease is breast cancer.